← SynDRA
STX-107
SynDRA canonical compound SYN1957112 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
| Primary target(s) | GRM5 |
| Mechanism of action | glutamate metabotropic receptor antagonist |
| Indication | parkinson's disease |
| Disease area | Neurology |
Cross-references
Synonyms
- 2-Methyl-4-(pyridin-3-ylethynyl)thiazole
- MTEP
- mGluR5 Antagonist, MTEP
- CHEMBL292065
- 3-((2-Methyl-1,3-thiazol-4-yl)ethynyl)pyridine
- 3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine
- 3-[2-(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine
- 3-(2-(2-methylthiazol-4-yl)ethynyl)pyridine
- 3-[2-(2-Methylthiazol-4-yl)ethynyl]pyridine
- 3-(2-Methyl-thiazol-4-ylethynyl)-pyridine
- SCHEMBL187254
- GTPL3336
- CTK1B8867
- DTXSID30430775
- ZINC1489321
- IN1238
- BDBM50122758
- FCH3417361
- API0006876
- ACN-027361
- KB-274670
Look up STX-107 in the interactive SynDRA portal →